Understand the source comparison
Comparison Table: GHRP-6 Acetate Legal Status Across Contexts
The legal boundaries for GHRP-6 acetate shift depending on purchase context, intended use, and marketing claims. This table clarifies when possession and use are compliant versus when they trigger regulatory enforcement. Research institution for in vitro study
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The legal boundaries for GHRP-6 acetate shift depending on purchase context, intended use, and marketing claims. This table clarifies when possession and use are compliant versus when they trigger regulatory enforcement.
- Research institution for in vitro study
- Research chemical
- Yes
- Yes (lab only)
- Low
- Label 'research use only,' no therapeutic claims
- Research institution for animal study
- Yes (animal models)
- IRB or IACUC protocol if required by institution
- Compounding pharmacy for patient prescription
- Unapproved new drug
- No (without IND)
- No (without clinical trial)
- High
- Requires FDA IND application and clinical trial authorization
- Individual purchase with 'research' label
- Yes (if labeled correctly)
- No (not for self-administration)
- Medium
- Supplier must not make therapeutic claims; buyer cannot administer to humans
- Sold with 'muscle growth' or 'anti-aging' claims
- No (violates FDCA)
- No
- Very high
- FDA Warning Letter and potential seizure
- Clinical trial under IND protocol
- Investigational new drug
- Yes (under IND)
- Yes (trial participants)
- Low (if protocol followed)
- Approved IND application, IRB oversight, informed consent